Not applicable (submitted trial is a bioequivalence study in healthy subject). research hub

Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril capsule, hard 10mg/5mg/5mg versus reference products Crestor 10 mg film coated tablets, Norvasc 5 mg tablets, Tritace 5 mg tablets in healthy male and female subjects under fasting conditions. Sponsor’s Study Number: ROS-AML-RAM-BIO-02-23

This study compares a new combination pill to separate existing medicines for heart health. It checks if the new pill works in the body the same way as the individual medicines, ensuring it's safe and effective for patients.